Syed Muhammad Azam Bokhari, Muhammad Arif Maan.
Ketotifen in chronic idiopathic Urticaria.
J Pak Assoc Derma Jan ;10(3):2-4.

This is an open prospective study to see the efficacy and safety of ketotifen in chronic idiopathic urticaria in twenty patients including 9(45%) males and 11(55%) females of 9 years to 49 years of age (Average 28.6 years). Duration of disease varied from 2 months to 5 years. One mg of ketotifen twice daily was given for 4 weeks with 3 month follow up. Ketotifen was effective and safe and effectively reduced the need of concomitant therapy in the treatment of chronic idiopathic urticaria.


USER COMMENTS

please,email me this article (full),thank you
Posted by: drjohn on May 2006

Please contact the medical journal directly for full text articles. PakMediNet do not provide full text.
Posted by: docosama on May 2006

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com